Cyanidin-3-O-β-glucoside attenuates allergic airway inflammation by modulating the IL-4Rα-STAT6 signaling pathway in a murine asthma model. [electronic resource]
- International immunopharmacology Apr 2019
- 1-10 p. digital
Publication Type: Journal Article
1878-1705
10.1016/j.intimp.2019.01.008 doi
Allergens--immunology Animals Anthocyanins--therapeutic use Anti-Inflammatory Agents--therapeutic use Asthma--drug therapy Cytokines--metabolism Dietary Supplements Disease Models, Animal Female Glucosides--therapeutic use Humans Lung--drug effects Mice Mice, Inbred BALB C Ovalbumin--immunology Receptors, Cell Surface--metabolism Respiratory Hypersensitivity--drug therapy STAT6 Transcription Factor--metabolism Th2 Cells--immunology